维生素D不足与认知谦逊:内分泌学会指南通讯
本文是内分泌学会的指南通讯,基于新委托的指南制定小组对4个临床问题的分析,指出现有临床试验证据不允许建立能预测维生素D补充带来有意义获益的25(OH)D阈值,且证据确定性极低,因此不再支持既往提出的维生素D「充足」和「不足」定义。
要点
- 现有临床试验证据不允许建立能预测维生素D补充有意义获益的25(OH)D阈值。
- 指南制定小组对现有证据的总体确定性为极低。
- 内分泌学会不再支持既往提出的维生素D「充足」(至少30 ng/mL)和「不足」定义。
核心结论
- 现有临床试验证据不允许建立能预测维生素D补充带来有意义获益的25(OH)D阈值。
- 内分泌学会不再支持其既往提出的维生素D「充足」定义(至少30 ng/mL [75 nmol/L])和「不足」定义(大于20 ng/mL [50 nmol/L]但低于30 ng/mL [75 nmol/L])。
研究设计与样本
- 本文为内分泌学会的指南通讯,基于新委托的指南制定小组优先关注的4个关于一般健康人群25(OH)D低于阈值时补充维生素D获益与危害的临床问题。
主要发现
- 指南制定小组确定现有临床试验证据不允许建立能预测维生素D补充有意义获益的25(OH)D阈值。
- 小组指出可用证据存在重要局限性,且对可用证据的总体确定性为极低。
- 自2011年内分泌学会首部维生素D相关指南发布以来,已发表多项大型维生素D相关随机临床试验。
关键数值与推荐
- 内分泌学会不再支持既往提出的维生素D「充足」定义:至少30 ng/mL(75 nmol/L)。
- 内分泌学会不再支持既往提出的维生素D「不足」定义:大于20 ng/mL(50 nmol/L)但低于30 ng/mL(75 nmol/L)。
局限性
- 小组指出可用证据存在重要局限性。
- 小组对可用证据的总体确定性为极低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A long-held precept is that vitamin D supplementation primarily, if not exclusively, benefits individuals with low circulating 25-hydroxyvitamin D (25[OH]D) concentrations at baseline. However, the most appropriate 25(OH)D threshold to distinguish unacceptably low vs reliably adequate concentrations remains controversial. Such threshold proposals have largely been based on observational studies, which provide less robust evidence compared to randomized clinical trials (RCTs). Since the Endocrine Society's first vitamin D-related guideline was published in 2011, several large vitamin D-related RCTs have been published, and a newly commissioned guideline development panel (GDP) prioritized 4 clinical questions related to the benefits and harms of vitamin D supplementation in generally healthy individuals with 25(OH)D levels below a threshold. The GDP determined that available clinical trial evidence does not permit the establishment of 25(OH)D thresholds that specifically predict meaningful benefit with vitamin D supplementation. The panel noted important limitations in the available evidence, and the panel's overall certainty in the available evidence was very low. Nonetheless, based on the GDP's analyses and judgments, the Endocrine Society no longer endorses its previously proposed definition of vitamin D "sufficiency" (ie, at least 30 ng/mL [75 nmol/L]) or its previously proposed definition of vitamin D "insufficiency" (ie, greater than 20 ng/mL [50 nmol/L] but lower than 30 ng/mL [75 nmol/L]). The Endocrine Society's rationale for such is the subject of this Guideline Communication.
引用
- McCartney CR, McDonnell ME, Corrigan MD, et al. Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication. J Clin Endocrinol Metab. 2024. PMID: 38828961. doi:10.1210/clinem/dgae322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。